Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes.

Journal: Practical radiation oncology
Published Date: Dec 3, 2015

Abstract

PURPOSE: To determine dosimetric factors predictive of hearing loss in vestibular schwannoma (VS) patients treated with definitive fractionated stereotactic radiation therapy (FSRT), and to report tumor control, serviceable hearing preservation, and cranial nerve toxicities.

Authors

  • Nathan R Bennion
    Departments of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: nathan.bennion@unmc.edu.
  • Ryan K Nowak
    Departments of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Elizabeth R Lyden
    Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska.
  • Robert B Thompson
    Departments of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Sicong Li
    Departments of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Chi Lin
    Departments of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska.

Keywords

External Resources

Popular Topics
Recent Journals